Devoted to Life —
Being Your Ideal
API Partner
Delivering excellence in Active Pharmaceutical Ingredients with quality, compliance and global trust across 25+ countries.
Everyone Belongs,
All Opinions
Are Valued
We foster an inclusive culture where innovation thrives and every voice drives pharmaceutical progress.
A Commitment to
Sustainability Within
Every Synthesis
Responsible manufacturing aligned with environmental stewardship and social accountability.
Globally Certified & Recognised
Trusted API Partner Delivering Quality & Innovation
Reine Lifescience is a globally recognised pharmaceutical API manufacturer based in Ankleshwar, India. With cGMP-compliant facilities and advanced infrastructure, we manufacture high-quality Active Pharmaceutical Ingredients for regulated markets worldwide.
Our integrated operations, experienced leadership, robust quality systems, and commitment to regulatory excellence position us as a reliable partner for pharmaceutical companies across 25+ countries.
Reine's API Expertise:
Capabilities at a Glance
At Reine Lifescience, we deliver integrated API manufacturing capabilities aligned with global regulatory standards — ensuring quality, scalability, and reliability for every partner worldwide.
Inside Reine —
Facilities & People
A glimpse into our world-class manufacturing infrastructure, dedicated team, and the science driving us forward.
Advanced API Manufacturing
for Global Markets
Reine Lifescience operates cGMP-compliant facilities delivering high-quality Active Pharmaceutical Ingredients to regulated markets worldwide.
- Modern infrastructure with integrated QA, QC & R&D
- International regulatory compliance across multiple markets
- Scalable manufacturing capacity for global supply chains
World-Class Synthesis Infrastructure
Our state-of-the-art manufacturing plant in Ankleshwar, Gujarat is equipped with glass-lined reactors, advanced purification systems, and full-scale QC laboratory capabilities designed to meet the most demanding international pharmacopoeia standards.
| # | Product | Therapeutic Category | Specifications | Regulatory Status |
|---|---|---|---|---|
| 1 | Amiodarone HCL | Anti-Arrhythmic | IP / BP / EP / USP / DMF | CEP Not Available |
| 2 | Apixaban | Anticoagulant | IH | Not Available |
| 3 | Atorvastatin Calcium | Cardiovascular | IP / BP / EP / USP | WHO-GMP |
| 4 | Atorvastatin Strontium | Cardiovascular | IH | Not Available |
| 5 | Baclofen | Antispasmodic | IP / BP / EP / USP | WHO-GMP |
| 6 | Benzocaine | Anaesthetics | BP / EP / USP | CEP Approved |
| 7 | Bilastine | Anti-Allergic | IP | Not Available |
| 8 | Deferasirox | Iron Chelator | IP / BP / EP | Not Available |
| 9 | Deferiprone | Iron Chelator | BP / EP | Not Available |
| 10 | Doxofylline | Anti-Asthmatic | IP / USP | WHO-GMP |
| 11 | Ethambutol HCL | Anti-Tubercular | IP / BP / EP / USP | Not Available |
| 12 | Febuxostat | DPP-4 | IH | WHO-GMP |
| 13 | Fenofibrate | Anti-Hyperlipidemic | IP / BP / EP / USP | Not Available |
| 14 | Itopride | Gastro Prokinetic | IH | Not Available |
| 15 | Labetalol HCL | Anti-Hypertension | IP / BP / EP / USP | Not Available |
| 16 | Letrozole | Anti-Estrogen | IP / BP / EP / USP | Not Available |
| 17 | Metoprolol Succinate | Anti-Hypertension | IP / BP / EP / USP | CEP Under Approval |
| 18 | Metoprolol Tartrate | Anti-Hypertension | IP / BP / EP / USP | CEP Under Approval |
| 19 | Minoxidil | Anti-Hypertension | IP / BP / EP / USP | Not Available |
| 20 | Mirogabalin Besylate | Neuropathic Pain | IH | Not Available |
| 21 | Phenylbutazone | NSAID | BP / EP / USP | CEP Approved |
| 22 | Pregabalin | Anti-Epilepsy | IP / BP / EP / USP | CEP Under Approval |
| 23 | Rosuvastatin Calcium | Cardiovascular | IP / BP / EP / USP | MFDS Korea |
| 24 | Sitagliptin Phosphate | DPP-4 | IP / BP / EP / USP | WHO-GMP |
| 25 | Teneligliptin HBr | Anti-Diabetic | IP | Not Available |
| 26 | Teneligliptin HCL | Anti-Diabetic | IH | Not Available |
| 27 | Torsemide | Anti-Hypertension | IP / BP / EP / USP | Not Available |
| 28 | Trazodone HCL | Anti-Depressant | IP / BP / EP / USP | WHO-GMP |
| 29 | Erdosteine | Anti-Mucolytic | IH | DMF |
| 30 | Bempedoic Acid | In Development | ||
| 31 | Fimasartan | In Development | ||
| 32 | Iopamidol | In Development | ||
| 33 | Luliconazole | In Development | ||
| 34 | Minoxidil Sulphate | In Development | ||
Three Decades of Excellence
From chemical intermediates to a globally-recognised pharmaceutical API manufacturer — our journey defined by quality and commitment.
Established as Reine Chemicals Pvt. Ltd.
Foundation laid with a vision to manufacture high-quality chemical intermediates in Ankleshwar, India.
Transition to Reine Lifescience
Strategic expansion into pharmaceutical APIs and regulated global markets.
WHO Inspection
Successful WHO inspection strengthening global regulatory credibility and market access.
CEP Customer Audit
Reinforcing regulatory alignment and quality excellence through rigorous external audits.
WHO-GMP Approval
Achieved WHO-GMP certification demonstrating advanced manufacturing compliance standards.
MFDS Korea Approval
Expanded regulatory footprint with Ministry of Food and Drug Safety, Korea certification.
Sri Lanka Audit
Successful regulatory delegation visit reinforcing quality alignment across South Asian markets.
Anvisa Inspection Completed
Strengthening regulatory presence across Latin America with successful Brazil Anvisa inspection.
Global Presence
International Expo & Events
Upcoming Expo
CPHI Worldwide 2026
📅 Oct 15, 2026
📍 Frankfurt, Germany
Booth B12
Arab Health 2026
📅 Jan 20, 2026
📍 Dubai, UAE
Booth C21
Pharmaconex
📅 Sept 2026
📍 Cairo, Egypt
Booth A05Past Expo
CPHI India
📅 Nov 2024
📍 Delhi, India
Expo EventArab Health
📅 Jan 2024
📍 Dubai, UAE
Expo EventCPHI China
📅 June 2024
📍 Shanghai, China
Expo EventReady to Partner with Reine?
Connect with our team to discuss API supply requirements, regulatory documentation, or custom manufacturing partnerships.